General Information of DTT (ID: TTWQM3J)

DTT Name Kynureninase (KYNU) DTT Info
Gene Name KYNU

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Preclinical Drug(s)
Investigative Drug(s)
2 Preclinical Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-Amino-4-[3-hydroxyphenyl]-4-hydroxybutanoic acid DM1R3VC Breast cancer 2C60-2C65 Preclinical [1]
S-(2-Aminophenyl)-L-cysteine S,S-dioxide DM9Y05C Bacterial infection 1A00-1C4Z Preclinical [2]
------------------------------------------------------------------------------------
4 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
3,6,9,12,15-Pentaoxaheptadecane DMY8IOP Discovery agent N.A. Investigative [3]
3-hydroxydesaminokynurenine DM5T6AM Discovery agent N.A. Investigative [4]
3-Hydroxyhippuric acid DM2LBFW Discovery agent N.A. Investigative [3]
3-methoxydesaminokynurenine DMHVIK3 Discovery agent N.A. Investigative [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 2-Amino-4-[3'-hydroxyphenyl]-4-hydroxybutanoic acid; a potent inhibitor of rat and recombinant human kynureninase. Bioorg Med Chem Lett. 2002 Feb 11;12(3):361-3.
2 Structure, mechanism, and substrate specificity of kynureninase. Biochim Biophys Acta. 2011 Nov;1814(11):1481-8.
3 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
4 Comparative inhibition by substrate analogues 3-methoxy- and 3-hydroxydesaminokynurenine and an improved 3 step purification of recombinant human kynureninase. BMC Biochem. 2003 Sep 24;4:13.